Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: A nomogram to better define patients who can be salvaged with further therapy

Journal of Clinical Oncology

Volumn 29, Issue 10, 2011, Pages 1319-1325

  Chisholm, Julia C ^{a,b,c,d,e,f,g}   Marandet, Julien ^{a,b,c,d,e,f,g}   Rey, Annie ^{a,b,c,d,e,f,g}   Scopinaro, Marcelo ^{a,b,c,d,e,f,g}   De Toledo, Jose Sánchez ^{a,b,c,d,e,f,g}   Merks, Johannes H M ^{a,b,c,d,e,f,g}   O'Meara, Anne ^{a,b,c,d,e,f,g}   Stevens, Michael C G ^{a,b,c,d,e,f,g}   Oberlin, Odile ^{a,b,c,d,e,f,g}  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Institute of Child Life and Health   (United Kingdom)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f EMMA CHILDREN S HOSPITAL   (Netherlands)

^g OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RHABDOMYOSARCOMA; SALVAGE THERAPY; SCHOOL CHILD; TUMOR VOLUME;

CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT TECHNIQUES; EUROPE; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; ODDS RATIO; PATIENT SELECTION; RHABDOMYOSARCOMA; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954440714     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.1984     Document Type: Article

References (13)

1. Crist WM, Anderson JR, Meza JL, et al: Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001 (Pubitemid 32567502)
2. Stevens MC, Rey A, Bouvet N, et al: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: Third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23:2618-2628, 2005 (Pubitemid 46179450)
3. Donaldson SS, Anderson JR: Rhabdomyosarcoma: Many similarities, a few philosophical differences. J Clin Oncol 23:2586-2587, 2005 (Pubitemid 46179444)
4. Oberlin O, Rey A, Anderson J, et al: The treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment-Results of an international workshop. J Clin Oncol 19:197-204, 2001 (Pubitemid 32063497)
5. Rodeberg DA, Anderson JR, Arndt CA, et al: Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Int J Cancer 10.1002/ijc.25444 [epub ahead of print on May 11, 2010]
6. Pappo AS, Anderson JR, Crist WM, et al: Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 17:3487-3493, 1999 (Pubitemid 29517919)
7. Mazzoleni S, Bisogno G, Garaventa A, et al: Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 104:183-190, 2005 (Pubitemid 40847767)
8. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology-MMT84. Eur J Cancer 34:1050-1062, 1998 (Pubitemid 28308346)
9. Stevens M, Rey A, Bouvet N, et al: SIOP MMT 95: Intensified (6 drug) versus standard (IVA) chemotherapy for high-risk nonmetastatic rhabdomyosarcoma (RMS). J Clin Oncol 23:798s, 2004 (suppl: abstr 8515)
10. Akaike H: Information theory and an extension of the maximum likelihood principle, in Petrov BN and Csaki F (eds): Proceedings of the Second International Symposium on Information Theory. Budapest, Hungary, Akademiai Kiad, 1973, pp 267-281
11. Iasonos A, Schrag D, Raj GV, et al: How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364-1370, 2008
12. Dantonello TM, Int-Veen C, Winkler P, et al: Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 26:406-413, 2008 (Pubitemid 351171692)
13. Mattke AC, Bailey EJ, Schuck A, et al: Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer 52:772-776, 2009